Direct-acting antivirals for chronic hepatitis C treatment: The experience of two tertiary university centers in Brazil

BACKGROUND: Hepatitis C virus (HCV) treatment has undergone major changes in recent years. Previous interferon-based therapies have been replaced by oral direct-acting antivirals (DAA) regimens, with high sustained virologic response (SVR) rates, and a lower incidence of adverse events (AEs). AIM: T...

Descripción completa

Detalles Bibliográficos
Autores principales: Lourenço, Mariana Sandoval, Zitelli, Patricia Momoyo Y, Cunha-Silva, Marlone, Oliveira, Arthur Ivan N, Oliveira, Cláudia P, Sevá-Pereira, Tiago, Carrilho, Flair José, Pessoa, Mario G, Mazo, Daniel F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Retrospective Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790388/
https://www.ncbi.nlm.nih.gov/pubmed/35126848
http://dx.doi.org/10.4254/wjh.v14.i1.195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790388/
https://www.ncbi.nlm.nih.gov/pubmed/35126848
http://dx.doi.org/10.4254/wjh.v14.i1.195

Ejemplares similares